Collectively, the results of this comparative analysis demonstrate that the case and control groups were well-matched in terms of gender, smoking status, and BMI, minimizing the potential confounding effects of these variables on the association between SNPs in CHRNA3 and COPD susceptibility. This evidence concerns the gene CHRNA3 and chronic obstructive pulmonary disease.